{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:46:43Z","timestamp":1791218803369,"version":"4.1.0"},"reference-count":37,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"\n Importance<\/jats:title>\n Adult T-cell leukemia\/lymphoma (ATLL) is a rare but highly aggressive malignant disease caused by lifelong infection with human T-cell leukemia virus type 1 (HTLV-1), typically acquired through mother-to-child transmission. In southwestern Japan, the world\u2019s highly documented HTLV-1 endemic region, maternal HTLV-1 screening and breastfeeding counseling have reduced vertical transmission. Because of the long latency between infection and disease, reductions in ATLL burden are expected to occur over time. In the US, HTLV-1 screening is limited to blood donors, while mother-to-child transmission remains unaddressed, despite growing immigrant populations from HTLV-1\u2013endemic regions.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To estimate ATLL incidence in the US by race, ethnicity, and birthplace, and to assess whether incidence in specific populations approaches levels observed in historically endemic regions with established maternal HTLV-1 screening programs.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n A population-based incidence and survival analysis was performed using cancer registries from all 50 US states. Individuals 15 years or older diagnosed with ATLL between 2005 and 2022 were included. Data analysis was conducted from December 2024 to November 2025.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n Race, ethnicity, and country of birth, with focused analyses of non-Hispanic Caribbean-born US residents originating from HTLV-1\u2013endemic regions, were examined.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The main outcomes were age-adjusted incidence rates, incidence rate ratios, temporal trends, sensitivity analyses accounting for misclassification with peripheral T-cell lymphoma not otherwise specified (PTCL-NOS), and cause-specific survival.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n A total of 3228 individuals with ATLL were identified. Among these individuals diagnosed with ATLL between 2005 and 2022, 1662 (51.5%) were male and 1566 (48.5%) were female, with a mean (SD) age at diagnosis of 61.1 (17.3) years, estimated from 5-year age group data. A total of 126 (3.9%) were non-Hispanic Asian or Pacific Islander, 1300 (40.3%) were non-Hispanic Black, 364 (11.3%) were Hispanic, 1394 (43.2%) were non-Hispanic White, and 44 (1.4%) were another race (including American Indian or Alaska Native, other or multiple race, and unknown race). Incidence varied by birthplace. Among non-Hispanic Caribbean-born US residents, the ATLL incidence rate was 14.1 per million, compared with 0.4 per million among US- or Canada-born populations (incidence rate ratio [IRR], 32.0; 95% CI, 27.9-36.8). Rates reached 33.7 per million among individuals born in Grenada. Sensitivity analyses redistributing excess PTCL-NOS incidence under a misclassification framework increased ATLL incidence among Caribbean-born populations to levels approaching or exceeding those reported in HTLV-1 endemic regions. Five-year survival was poor (23.8%; 95% CI, 21.1%-26.5%) and lowest among Caribbean-born individuals.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n This cross-sectional analysis found that ATLL incidence among non-Hispanic Caribbean-born US residents approached that of historically endemic regions. Since 2000, more than 300\u202f000 births to Caribbean-born mothers have occurred in Florida alone, underscoring the scale of unaddressed early-life HTLV-1 exposure in the absence of maternal screening. These findings identify early-life infection as an actionable target for cancer prevention, with implications for reducing future ATLL burden.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamaoncol.2026.0859","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:31:06Z","timestamp":1777563066000},"page":"628","source":"Crossref","is-referenced-by-count":3,"title":["Adult T-Cell Leukemia\/Lymphoma and Targeted Maternal Screening"],"prefix":"10.1001","volume":"12","author":[{"given":"Paulo S.","family":"Pinheiro","sequence":"first","affiliation":[{"name":"Division of Epidemiology & Population Health Sciences, Department of Public Health Sciences, University of Miami School of Medicine, Miami, Florida"},{"name":"Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tabassum Z.","family":"Insaf","sequence":"additional","affiliation":[{"name":"Bureau of Cancer Epidemiology, New York State Department of Health, Albany"},{"name":"Department of Epidemiology and Biostatistics, School of Public Health, University at Albany, State University of New York, Rensselaer"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber N.","family":"Balda","sequence":"additional","affiliation":[{"name":"Division of Epidemiology & Population Health Sciences, Department of Public Health Sciences, University of Miami School of Medicine, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baozhen","family":"Qiao","sequence":"additional","affiliation":[{"name":"Bureau of Cancer Epidemiology, New York State Department of Health, Albany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia H. L.","family":"George","sequence":"additional","affiliation":[{"name":"Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Okuyama","sequence":"additional","affiliation":[{"name":"Graduate School of Nursing, St Luke\u2019s International University, Chuo-ku, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Ramos","sequence":"additional","affiliation":[{"name":"Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3-4","key":"coi260015r1","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/jemt.20231","article-title":"The human T-cell leukemia virus type 1 (HTLV-1): new insights into the clinical aspects and molecular pathogenesis of adult T-cell leukemia\/lymphoma (ATLL) and tropical spastic paraparesis\/HTLV-associated myelopathy (TSP\/HAM).","volume":"68","author":"Shuh","year":"2005","journal-title":"Microsc Res Tech"},{"issue":"10","key":"coi260015r2","doi-asserted-by":"publisher","first-page":"6476","DOI":"10.1073\/pnas.78.10.6476","article-title":"Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera.","volume":"78","author":"Hinuma","year":"1981","journal-title":"Proc Natl Acad Sci U S A"},{"key":"coi260015r3","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3389\/fmicb.2012.00388","article-title":"Epidemiological aspects and world distribution of HTLV-1 infection.","volume":"3","author":"Gessain","year":"2012","journal-title":"Front Microbiol"},{"issue":"39","key":"coi260015r4","doi-asserted-by":"publisher","first-page":"6058","DOI":"10.1038\/sj.onc.1208968","article-title":"Global epidemiology of HTLV-I infection and associated diseases.","volume":"24","author":"Proietti","year":"2005","journal-title":"Oncogene"},{"issue":"11","key":"coi260015r5","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/S1473-3099(16)30252-3","article-title":"Incidence of human T-lymphotropic virus 1 infection in adolescent and adult blood donors in Japan: a nationwide retrospective cohort analysis.","volume":"16","author":"Satake","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"coi260015r6","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00078-21","article-title":"Clinical and public health implications of human T-lymphotropic virus type 1 infection.","volume":"35","author":"Legrand","year":"2022","journal-title":"Clin Microbiol Rev"},{"issue":"8","key":"coi260015r7","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/aps.2017.17","article-title":"Human T-cell lymphotropic virus type 1 and its oncogenesis.","volume":"38","author":"Zhang","year":"2017","journal-title":"Acta Pharmacol Sin"},{"issue":"10","key":"coi260015r8","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.3390\/v17101333","article-title":"HTLV-1 and ATLL: epidemiology, oncogenesis, and opportunities for community-informed research in the United States.","volume":"17","author":"Altieri","year":"2025","journal-title":"Viruses"},{"issue":"9","key":"coi260015r9","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1182\/blood-2016-09-692574","article-title":"Adult T-cell leukemia: molecular basis for clonal expansion and transformation of HTLV-1-infected T cells.","volume":"129","author":"Watanabe","year":"2017","journal-title":"Blood"},{"issue":"6","key":"coi260015r10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3390\/v8060161","article-title":"HTLV-1 infection and adult T-cell leukemia\/lymphoma-a tale of two proteins: tax and HBZ.","volume":"8","author":"Giam","year":"2016","journal-title":"Viruses"},{"issue":"14","key":"coi260015r11","doi-asserted-by":"publisher","first-page":"3438","DOI":"10.1002\/cncr.25147","article-title":"A critical analysis of prognostic factors in North American patients with human T-cell lymphotropic virus type-1-associated adult T-cell leukemia\/lymphoma: a multicenter clinicopathologic experience and new prognostic score.","volume":"116","author":"Phillips","year":"2010","journal-title":"Cancer"},{"key":"coi260015r12","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3389\/fmicb.2020.00595","article-title":"A nationwide antenatal human T-cell leukemia virus type-1 antibody screening in Japan.","volume":"11","author":"Itabashi","year":"2020","journal-title":"Front Microbiol"},{"issue":"1","key":"coi260015r13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S1473-3099(18)30735-7","article-title":"Towards the elimination of HTLV-1 infection in Japan.","volume":"19","author":"Nishijima","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"coi260015r14","doi-asserted-by":"publisher","first-page":"152","DOI":"10.2183\/pjab.87.152","article-title":"Establishment of the milk-borne transmission as a key factor for the peculiar endemicity of human T-lymphotropic virus type 1 (HTLV-1): the ATL Prevention Program Nagasaki.","volume":"87","author":"Hino","year":"2011","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"issue":"4","key":"coi260015r15","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1080\/10428194.2023.2173524","article-title":"A decrease in newly diagnosed patients with adult T-cell leukemia\/lymphoma in Kagoshima, a highly endemic area of HTLV-1 in southwestern Japan.","volume":"64","author":"Owatari","year":"2023","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"coi260015r16","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1182\/bloodadvances.2017011106","article-title":"Epidemiology, clinical features, and outcome of HTLV-1-related ATLL in an area of prevalence in the United States.","volume":"2","author":"Malpica","year":"2018","journal-title":"Blood Adv"},{"issue":"3","key":"coi260015r17","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/cncr.32556","article-title":"Epidemiology and survival trend of adult T-cell leukemia\/lymphoma in the United States.","volume":"126","author":"Shah","year":"2020","journal-title":"Cancer"},{"issue":"26","key":"coi260015r18","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1182\/blood-2016-09-739433","article-title":"Screening transplant donors for HTLV-1 and -2.","volume":"128","author":"Gallo","year":"2016","journal-title":"Blood"},{"issue":"2","key":"coi260015r19","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1001\/jama.284.2.229","article-title":"Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996.","volume":"284","author":"Glynn","year":"2000","journal-title":"JAMA"},{"issue":"7","key":"coi260015r20","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/s41379-018-0037-3","article-title":"Adult T-cell leukemia\/lymphoma can be indistinguishable from other more common T-cell lymphomas: the University of Miami experience with a large cohort of cases.","volume":"31","author":"Khanlari","year":"2018","journal-title":"Mod Pathol"},{"issue":"12","key":"coi260015r21","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1182\/blood-2010-09-310342","article-title":"Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project.","volume":"117","author":"Weisenburger","year":"2011","journal-title":"Blood"},{"issue":"25","key":"coi260015r24","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes.","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol"},{"key":"coi260015r26","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3389\/fmicb.2012.00322","article-title":"Adult T-cell leukemia: a review of epidemiological evidence.","volume":"3","author":"Iwanaga","year":"2012","journal-title":"Front Microbiol"},{"issue":"5","key":"coi260015r27","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1080\/10428194.2017.1365862","article-title":"Diagnostic challenges of adult T-cell leukemia\/lymphoma in North America\u2014a clinical, histological, and immunophenotypic correlation with a workflow proposal.","volume":"59","author":"Licata","year":"2018","journal-title":"Leuk Lymphoma"},{"issue":"32","key":"coi260015r28","doi-asserted-by":"publisher","first-page":"51981","DOI":"10.18632\/oncotarget.10223","article-title":"Adult T-cell leukemia\/lymphoma in the Caribbean cohort is a distinct clinical entity with dismal response to conventional chemotherapy.","volume":"7","author":"Zell","year":"2016","journal-title":"Oncotarget"},{"issue":"14","key":"coi260015r29","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1182\/blood-2018-01-824607","article-title":"North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies.","volume":"132","author":"Shah","year":"2018","journal-title":"Blood"},{"issue":"11","key":"coi260015r30","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1007\/s10552-017-0960-5","article-title":"Twenty-first century cancer patterns in small island nations: Grenada and the English-speaking Caribbean.","volume":"28","author":"Cattin","year":"2017","journal-title":"Cancer Causes Control"},{"issue":"49","key":"coi260015r31","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.15585\/mmwr.mm6549a3","article-title":"Leading causes of cancer mortality\u2014Caribbean region, 2003-2013.","volume":"65","author":"Razzaghi","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"8","key":"coi260015r32","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1182\/blood-2009-12-257410","article-title":"Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan.","volume":"116","author":"Iwanaga","year":"2010","journal-title":"Blood"},{"issue":"6","key":"coi260015r33","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1111\/bjh.15234","article-title":"Can we reduce the incidence of adult T-cell leukaemia\/lymphoma? cost-effectiveness of human T-lymphotropic virus type 1 (HTLV-1) antenatal screening in the United Kingdom.","volume":"184","author":"Malik","year":"2019","journal-title":"Br J Haematol"},{"issue":"2","key":"coi260015r35","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/ijc.2910430214","article-title":"Modelling the risk of adult T-cell leukemia\/lymphoma in persons infected with human T-lymphotropic virus type I.","volume":"43","author":"Murphy","year":"1989","journal-title":"Int J Cancer"},{"key":"coi260015r36","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.941647","article-title":"A review of the prevention of mother-to-child transmission of human T-Cell lymphotrophic virus type 1 (HTLV-1) with a proposed management algorithm.","volume":"9","author":"Barr","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"coi260015r37","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.881547","article-title":"HTLV-1 transmission and HIV pre-exposure prophylaxis: a scoping review.","volume":"9","author":"Bradshaw","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"coi260015r22","unstructured":"North American Association of Central Cancer Registries. CiNA research data set for researchers. Accessed July 31, 2025. https:\/\/www.naaccr.org\/cina-research\/"},{"key":"coi260015r23","unstructured":"Ruggles? S, Flood? S, Sobek? M, . Data from: IPUMS USA (Version 16.0.). Accessed November 29, 2024. https:\/\/usa.ipums.org\/usa\/"},{"key":"coi260015r25","unstructured":"Surveillance Research Program, National Cancer Institute. Joinpoint Regression Software (version 5.4.0.). Accessed July 31, 2025. https:\/\/surveillance.cancer.gov\/joinpoint"},{"key":"coi260015r34","unstructured":"Florida Department of Health - Bureau of Vital Statistics. Birth Certificates (2000-2023). Accessed July 31, 2025. https:\/\/www.floridahealth.gov\/certificates\/certificates\/birth\/index.html"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2848245\/jamaoncology_pinheiro_2026_oi_260015_1781656666.72719.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T15:00:49Z","timestamp":1781794849000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2848245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2026.0859","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,1]]}}}